Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBO-DN study of duloxetine and pregabalin in painful diabetic neuropathy
2009-010063-16Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine and pregabalin in diabetic polyneuropathy (DPN) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: BPI Modified Short Form 24-hour average pain item score. Started Aug 2009; status: completed.
02
Drugs
duloxetinepregabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2009-010063-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010063-16.